STUB1 and osteoporosis: In addition, CHIP is associated with adverse outcomes and age-related diseases beyond hematologic malignancies, including cardiovascular disease (CVD) [6, 13], type 2 diabetes mellitus [6], osteoporosis [14], gout [15], chronic liver disease [16], and autoimmune disease [17].